Uncoupling the CRMP2-Ca

CRMP2 Ca(V)2.2 Osteoarthritis pain collapsin response mediator protein 2 voltage gated calcium channel 2.2

Journal

The journal of pain
ISSN: 1528-8447
Titre abrégé: J Pain
Pays: United States
ID NLM: 100898657

Informations de publication

Date de publication:
02 Sep 2024
Historique:
received: 06 06 2024
revised: 29 08 2024
accepted: 29 08 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: aheadofprint

Résumé

Osteoarthritis (OA) represents a significant pain challenge globally, as current treatments are limited and come with substantial and adverse side effects. Voltage-gated calcium channels have proved to be pharmacologically effective targets, with multiple FDA-approved Ca

Identifiants

DOI: 10.1016/j.jpain.2024.104664 PMID: 39233208
pubmed: 39233208
pii: S1526-5900(24)00620-5
doi: 10.1016/j.jpain.2024.104664
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104664

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Heather N Allen (HN)

Department of Pharmacology & Therapeutics, University of Florida College of Medicine, Gainesville, Florida 32610, USA.

Sara Hestehave (S)

Department of Molecular Pathobiology, College of Dentistry, New York University, New York, New York 10010, USA; Current address: Department of Experimental Medicine, University of Copenhagen, 2200 Copenhagen N, Denmark.

Paz Duran (P)

Department of Molecular Pathobiology, College of Dentistry, New York University, New York, New York 10010, USA.

Tyler S Nelson (TS)

Department of Pharmacology & Therapeutics, University of Florida College of Medicine, Gainesville, Florida 32610, USA.

Rajesh Khanna (R)

Department of Pharmacology & Therapeutics, University of Florida College of Medicine, Gainesville, Florida 32610, USA. Electronic address: r.khanna@ufl.edu.

Classifications MeSH